SPECIAL REPORT
First-line use of ocrelizumab
CONSONANCE study in progressive MS
Safety in pregnancy
Treatment effects in the CNS
Read More
Neurology
ACTRIMS Forum 2025: Update on biomarkers
March 17, 2025ACTRIMS Forum 2025 highlights – Focus on ofatumumab
March 10, 2025ACTRIMS Forum 2025 Highlights – Saturday, March 1, 2025
March 1, 2025The following summarizes some of the highlights from Day 2 if the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum 2025.
ACTRIMS Forum 2025 Highlights – Friday, February 28, 2025
February 28, 2025The following summarizes some of the highlights from Day 1 of the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum 2025.